Radiation therapy firm Varian Medical Systems has promoted a number of executives.
Dow Wilson, executive vice president, has been appointed chief operating officer (COO), with responsibility for guiding and directing the development, production, promotion, and sale of all Varian products and services throughout the world, according to the vendor. He will be responsible for Varian's Oncology Systems, X-Ray Products, Particle Therapy, and Security and Inspection Products businesses. Wilson will continue to report to President and CEO Timothy Guertin.
Varian has also named Kolleen Kennedy as senior vice president and president of the Oncology Systems division. Kennedy, who will report to Wilson, has been vice president and general manager of customer support services for Oncology Systems.
Filling Kennedy's prior shoes as vice president and general manager of oncology customer support services will be Patrick Joda, who's currently serving as vice president of oncology worldwide engineering. In addition, Martin Amstutz will take over Joda's previous responsibilities with the title of vice president of worldwide engineering for Oncology Systems.
Varian has also named Vy Tran as vice president of regulatory affairs and quality assurance, reporting directly to the CEO. She will be responsible for quality systems compliance, quality assurance, internal audits, document control, postmarket surveillance reporting, and quality systems training for Varian's worldwide manufacturing sites. Tran, who joined Varian in 1998, is also responsible for the firm's regulatory clearance and approval strategies.
